336 related articles for article (PubMed ID: 17027339)
21. Leucine-Rich Repeat Kinase 2 interacts with Parkin, DJ-1 and PINK-1 in a Drosophila melanogaster model of Parkinson's disease.
Venderova K; Kabbach G; Abdel-Messih E; Zhang Y; Parks RJ; Imai Y; Gehrke S; Ngsee J; Lavoie MJ; Slack RS; Rao Y; Zhang Z; Lu B; Haque ME; Park DS
Hum Mol Genet; 2009 Nov; 18(22):4390-404. PubMed ID: 19692353
[TBL] [Abstract][Full Text] [Related]
22. Parkinson's disease: insights from pathways.
Cookson MR; Bandmann O
Hum Mol Genet; 2010 Apr; 19(R1):R21-7. PubMed ID: 20421364
[TBL] [Abstract][Full Text] [Related]
23. Emerging pathways in genetic Parkinson's disease.
Lewis PA
FEBS J; 2008 Dec; 275(23):5747. PubMed ID: 19021751
[No Abstract] [Full Text] [Related]
24. Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection.
Mukherjee UA; Ong SB; Ong SG; Hausenloy DJ
Pharmacol Ther; 2015 Dec; 156():34-43. PubMed ID: 26481155
[TBL] [Abstract][Full Text] [Related]
25. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.
Choi JM; Woo MS; Ma HI; Kang SY; Sung YH; Yong SW; Chung SJ; Kim JS; Shin HW; Lyoo CH; Lee PH; Baik JS; Kim SJ; Park MY; Sohn YH; Kim JH; Kim JW; Lee MS; Lee MC; Kim DH; Kim YJ
Neurogenetics; 2008 Oct; 9(4):263-9. PubMed ID: 18704525
[TBL] [Abstract][Full Text] [Related]
26. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
Camargos ST; Dornas LO; Momeni P; Lees A; Hardy J; Singleton A; Cardoso F
Mov Disord; 2009 Apr; 24(5):662-6. PubMed ID: 19205068
[TBL] [Abstract][Full Text] [Related]
27. [Function study advances of Parkinson disease related genes].
Wang XM; Wang DQ; Wang XY
Yi Chuan; 2010 Aug; 32(8):779-84. PubMed ID: 20709674
[TBL] [Abstract][Full Text] [Related]
28. Dysregulated Interorganellar Crosstalk of Mitochondria in the Pathogenesis of Parkinson's Disease.
Sironi L; Restelli LM; Tolnay M; Neutzner A; Frank S
Cells; 2020 Jan; 9(1):. PubMed ID: 31963435
[TBL] [Abstract][Full Text] [Related]
29. Microglia and astrocyte dysfunction in parkinson's disease.
Kam TI; Hinkle JT; Dawson TM; Dawson VL
Neurobiol Dis; 2020 Oct; 144():105028. PubMed ID: 32736085
[TBL] [Abstract][Full Text] [Related]
30. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
[TBL] [Abstract][Full Text] [Related]
31. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease].
Iwatsubo T; Ito G; Takatori S; Hannno Y; Kuwahara T
Rinsho Shinkeigaku; 2005 Nov; 45(11):899-901. PubMed ID: 16447757
[TBL] [Abstract][Full Text] [Related]
32. From genes to proteins in mendelian Parkinson's disease: an overview.
Pirkevi C; Lesage S; Brice A; Başak AN
Anat Rec (Hoboken); 2009 Dec; 292(12):1893-901. PubMed ID: 19943343
[TBL] [Abstract][Full Text] [Related]
33. [Mitochondrial dysfunction and oxidative damages in the molecular pathology of Parkinson's disease].
Shadrina MI; Slominskiĭ PA
Mol Biol (Mosk); 2008; 42(5):809-19. PubMed ID: 18988530
[TBL] [Abstract][Full Text] [Related]
34. Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells.
Ortiz-Ortiz MA; Morán JM; Ruiz-Mesa LM; Niso-Santano M; Bravo-SanPedro JM; Gómez-Sánchez R; González-Polo RA; Fuentes JM
Neurosci Lett; 2010 Jan; 468(2):120-4. PubMed ID: 19879924
[TBL] [Abstract][Full Text] [Related]
35. Molecular insights into Parkinson's disease.
Rochet JC; Hay BA; Guo M
Prog Mol Biol Transl Sci; 2012; 107():125-88. PubMed ID: 22482450
[TBL] [Abstract][Full Text] [Related]
36. The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans.
Bornhorst J; Chakraborty S; Meyer S; Lohren H; Brinkhaus SG; Knight AL; Caldwell KA; Caldwell GA; Karst U; Schwerdtle T; Bowman A; Aschner M
Metallomics; 2014 Mar; 6(3):476-90. PubMed ID: 24452053
[TBL] [Abstract][Full Text] [Related]
37. Disease model organism for Parkinson disease: Drosophila melanogaster.
Aryal B; Lee Y
BMB Rep; 2019 Apr; 52(4):250-258. PubMed ID: 30545438
[TBL] [Abstract][Full Text] [Related]
38. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
Dodson MW; Guo M
Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
[TBL] [Abstract][Full Text] [Related]
39. Parkinsonism genes: culprits and clues.
Abeliovich A; Flint Beal M
J Neurochem; 2006 Nov; 99(4):1062-72. PubMed ID: 16836655
[TBL] [Abstract][Full Text] [Related]
40. Multiplex ligation-dependent probe amplification assay for simultaneous detection of Parkinson's disease gene rearrangements.
Scarciolla O; Brancati F; Valente EM; Ferraris A; De Angelis MV; Valbonesi S; Garavaglia B; Uncini A; Palka G; Stuppia L; Dallapiccola B
Mov Disord; 2007 Nov; 22(15):2274-8. PubMed ID: 17914726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
